JP2014517692A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014517692A5 JP2014517692A5 JP2014511591A JP2014511591A JP2014517692A5 JP 2014517692 A5 JP2014517692 A5 JP 2014517692A5 JP 2014511591 A JP2014511591 A JP 2014511591A JP 2014511591 A JP2014511591 A JP 2014511591A JP 2014517692 A5 JP2014517692 A5 JP 2014517692A5
- Authority
- JP
- Japan
- Prior art keywords
- hns
- composition
- item
- column
- bulk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 108010089932 heparan sulfate sulfatase Proteins 0.000 claims description 55
- 238000000034 method Methods 0.000 claims description 49
- 239000000203 mixture Substances 0.000 claims description 30
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 24
- 239000012539 chromatography resin Substances 0.000 claims description 19
- 239000011780 sodium chloride Substances 0.000 claims description 12
- 238000005571 anion exchange chromatography Methods 0.000 claims description 8
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims description 7
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims description 7
- 239000011347 resin Substances 0.000 claims description 6
- 229920005989 resin Polymers 0.000 claims description 6
- 239000007983 Tris buffer Substances 0.000 claims description 5
- 241001460678 Napo <wasp> Species 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 4
- 238000005277 cation exchange chromatography Methods 0.000 claims description 4
- 238000004191 hydrophobic interaction chromatography Methods 0.000 claims description 4
- 241000700605 Viruses Species 0.000 claims description 2
- 230000002209 hydrophobic effect Effects 0.000 claims 4
- 230000003993 interaction Effects 0.000 claims 4
- 238000000746 purification Methods 0.000 claims 3
- 239000007858 starting material Substances 0.000 claims 3
- 208000002678 Mucopolysaccharidoses Diseases 0.000 claims 2
- 238000005349 anion exchange Methods 0.000 claims 2
- 238000005341 cation exchange Methods 0.000 claims 2
- 206010028093 mucopolysaccharidosis Diseases 0.000 claims 2
- 238000005406 washing Methods 0.000 claims 2
- 238000010828 elution Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000003480 eluent Substances 0.000 description 5
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
- 235000017281 sodium acetate Nutrition 0.000 description 4
- 239000001632 sodium acetate Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 description 2
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- VBAOEVKQBLGWTH-UHFFFAOYSA-N 2-pyridin-4-ylethanethiol Chemical compound SCCC1=CC=NC=C1 VBAOEVKQBLGWTH-UHFFFAOYSA-N 0.000 description 1
- 239000012564 Q sepharose fast flow resin Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000011026 diafiltration Methods 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161488090P | 2011-05-19 | 2011-05-19 | |
| US61/488,090 | 2011-05-19 | ||
| PCT/US2012/038630 WO2012159053A1 (en) | 2011-05-19 | 2012-05-18 | Process for purifying heparan-n-sulfatase |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016214041A Division JP2017029170A (ja) | 2011-05-19 | 2016-11-01 | ヘパラン−ｎ−スルファターゼを精製するためのプロセス |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014517692A JP2014517692A (ja) | 2014-07-24 |
| JP2014517692A5 true JP2014517692A5 (enExample) | 2015-07-02 |
Family
ID=47177365
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014511591A Ceased JP2014517692A (ja) | 2011-05-19 | 2012-05-18 | ヘパラン−ｎ−スルファターゼを精製するためのプロセス |
| JP2016214041A Pending JP2017029170A (ja) | 2011-05-19 | 2016-11-01 | ヘパラン−ｎ−スルファターゼを精製するためのプロセス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016214041A Pending JP2017029170A (ja) | 2011-05-19 | 2016-11-01 | ヘパラン−ｎ−スルファターゼを精製するためのプロセス |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20120329133A1 (enExample) |
| EP (2) | EP2929892B1 (enExample) |
| JP (2) | JP2014517692A (enExample) |
| AR (1) | AR086445A1 (enExample) |
| CA (1) | CA2836599A1 (enExample) |
| HK (1) | HK1214960A1 (enExample) |
| TW (1) | TW201307563A (enExample) |
| WO (1) | WO2012159053A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11584777B2 (en) | 2017-08-31 | 2023-02-21 | Green Cross Corporation | Method for purifying a sulfatase protein |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1460131A3 (en) * | 2000-03-22 | 2005-06-01 | Octagene GmbH | Production of recombinant blood clotting factors in human cell lines |
| JP4319979B2 (ja) * | 2002-04-26 | 2009-08-26 | ジェネンテック・インコーポレーテッド | タンパク質の非アフィニティ精製 |
| US7118901B2 (en) * | 2002-12-18 | 2006-10-10 | Roche Diagnostics Operations, Inc. | Recombinant bovine pancreatic desoxyribonuclease I with high specific activity |
| WO2005077093A2 (en) * | 2004-02-06 | 2005-08-25 | Biomarin Pharmaceutical Inc. | Manufacture of highly phosphorylated lysosomal enzymes and uses thereof |
| CA2592261C (en) * | 2004-12-10 | 2015-11-24 | Zymogenetics Inc. | Fgf18 production in prokaryotic hosts |
| EP2141178A4 (en) * | 2007-04-02 | 2010-05-19 | Kyowa Hakko Kirin Co Ltd | PROCESS FOR PRODUCING ANTITHROMBIN COMPOSITION |
| KR101744142B1 (ko) * | 2008-01-18 | 2017-06-07 | 바이오마린 파머수티컬 인크. | 활성이고 높은 정도로 인산화된 인간 리소좀 술파타아제 효소의 제조 및 그 용도 |
| MX2013000320A (es) * | 2010-06-25 | 2013-06-05 | Shire Human Genetic Therapies | Composiciones y metodos para suministro al sistema nervioso central de heparan n-sulfatasa. |
-
2012
- 2012-05-17 TW TW101117561A patent/TW201307563A/zh unknown
- 2012-05-18 WO PCT/US2012/038630 patent/WO2012159053A1/en not_active Ceased
- 2012-05-18 US US13/475,568 patent/US20120329133A1/en not_active Abandoned
- 2012-05-18 EP EP15166651.8A patent/EP2929892B1/en active Active
- 2012-05-18 CA CA2836599A patent/CA2836599A1/en not_active Abandoned
- 2012-05-18 JP JP2014511591A patent/JP2014517692A/ja not_active Ceased
- 2012-05-18 EP EP12785579.9A patent/EP2709654A4/en not_active Withdrawn
- 2012-05-18 AR ARP120101760A patent/AR086445A1/es unknown
-
2016
- 2016-03-15 HK HK16102969.5A patent/HK1214960A1/en unknown
- 2016-11-01 JP JP2016214041A patent/JP2017029170A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012018171A5 (enExample) | ||
| MY188566A (en) | Method to improve virus removal in protein purification | |
| RU2015120458A (ru) | Очистка полипептидов с использованием двухстадийной ультрафильтрации в тангенциальном потоке | |
| JP2014507368A5 (enExample) | ||
| MX392274B (es) | Cartuchos utiles en limpieza de soluciones de dialisis. | |
| JP2015071629A5 (enExample) | ||
| JP2016519137A5 (enExample) | ||
| JP2013099364A5 (enExample) | ||
| MX2019015304A (es) | Amortiguador de lavado para cromatografia de intercambio cationico. | |
| EA201691696A1 (ru) | Способы очистки матричной рнк | |
| JP2013511566A5 (enExample) | ||
| JP2016511238A5 (enExample) | ||
| NZ590257A (en) | Method of preparing alpha-1 proteinase inhibitor | |
| JP2016538128A5 (enExample) | ||
| JP2017510305A5 (enExample) | ||
| JP2017075175A (ja) | 洗浄用組成物、タンパク質精製方法、及びタンパク質 | |
| Moraes et al. | Expanded and fixed bed ion exchange chromatography for the recovery of C‐phycocyanin in a single step by using lysed cells | |
| CN104818254A (zh) | 离子交换色谱纯化口蹄疫灭活病毒抗原的方法 | |
| RU2015125059A (ru) | Обработка табачного материала | |
| CN104892734B (zh) | 疏水作用层析提纯口蹄疫灭活病毒抗原的方法 | |
| CN103145813B (zh) | 一种分离纯化重组蛋白a的方法 | |
| CN103725664A (zh) | 一种高度纯化激肽释放酶的方法 | |
| RU2018138445A (ru) | Способ очистки белка | |
| JP2013194054A5 (enExample) | ||
| JP2007523883A5 (enExample) |